MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$63,569K
(-884.96%↓ Y/Y)
Gene Dx
$100,733K
(17.46%↑ Y/Y)
All Other Segments
$566K
Gene Dx
$763K
(-43.73%↓ Y/Y)
All Other Segments
$192K
Net loss
-$63,316K
(-869.77%↓ Y/Y)
Unrealized (gain) loss
related to available for...
-$253K
(-437.33%↓ Y/Y)
Diagnostic Test
$101,299K
(18.12%↑ Y/Y)
Product And Service
Other
$955K
(-29.57%↓ Y/Y)
Loss before income
taxes
-$62,419K
(-926.29%↓ Y/Y)
Income tax expense
$897K
(100.67%↑ Y/Y)
Total revenue
$102,254K
(17.38%↑ Y/Y)
Loss from operations
-$57,471K
(-1162.82%↓ Y/Y)
Total non-operating
expense, net
-$4,948K
(-223.19%↓ Y/Y)
Gross profit
$68,211K
(16.65%↑ Y/Y)
Change in fair value of
financial liabilities
$2,540K
(330.91%↑ Y/Y)
Cost of services
$34,043K
(18.87%↑ Y/Y)
Selling, general and
administrative
$74,591K
Loss on
extinguishment of debt
-$6,565K
Impairment loss
$31,287K
Research and development
$19,804K
(57.46%↑ Y/Y)
Interest expense, net
-$717K
(-12.03%↓ Y/Y)
Other (expense)
income, net
-$206K
(-198.56%↓ Y/Y)
Back
Back
Income Statement
GeneDx Holdings Corp. (WGS)
GeneDx Holdings Corp. (WGS)
source: myfinsight.com